Future LRMN Events
LRMN & Cell Therapy Catapult
The December 2014 meeting of the LRMN will be focused on cell therapy commercialisation. Three experts with differing experiences from academic and commercial settings will be presenting their thoughts and experiences in getting to market.
This meeting is the third meeting supported by the Cell Therapy Catapult and is FREE OF CHARGE to attend. The Cell Therapy Catapult was established in 2012 as a centre of excellence in innovation, with the core purpose of building a world-leading cell therapy industry in the UK. Supported by Innovate UK (formerly the Technology Strategy Board), it's mission is to drive the growth of the industry by helping cell therapy organisations across the world translate early stage research into commercially viable and investable therapies. Based in London at Guy's Hospital, the centre focusses on collaboration and lowering barriers to investment and funding.
The meeting will take place on Monday 8th December 2014 at 6.00pm in the Darwin Lecture Theatre, Darwin Building, University College London - a short walk from Euston Square, Goodge Street and Warren Street Tube Stations and Euston Station.
Registration: 6.00 - 6.30pm
Presentations: 6.30 - 8.25pm
Networking Reception 8.25 - 10.00pm
18.00 - Registration and networking over tea and coffee in the Darwin Lecture Theatre (Darwin Building, UCL), while previewing the LRMN Cell Therapy Masterclass with Dr. Paul Kemp, CEO, Intercytex (Manchester, UK)
18.30 - Welcome - Matthew Durdy (Cell Therapy Catapult) and Dr. Emily Culme-Seymour (LRMN)
18.35 - Traversing the 3Rs: Regeneration, Regulation, and Reimbursement - Dr. Tania Bubela, University of Alberta (Edmonton, AB, Canada)
19.05 - Q & A
19.10 - Those who do not learn from history are bound to repeat it: Lessons learned from commercialisation of 3 cell therapies - Dr. Sven Kili, Sanofi Biosurgery (Oxford, UK)
19.40 - Q & A
19.45 - CMC: Can't Make Cells? - Dr. Anthony Davies, Dark Horse Consulting, Inc. (CA, US)
20.15 - Q & A
20.20 - Closing remarks - Matthew Durdy (Cell Therapy Catapult) and Dr. Emily Culme-Seymour (LRMN)
20.25 - 22.00 - LRMN Reception - Network whilst enjoying a glass of wine or two in the Darwin Building, UCL
SPONSORS + PARTNERS
CORPORATE SPONSOR: Cell Therapy Catapult
PROMOTIONAL SUPPORT: 'Regenerative Medicine'
PLEASE NOTE THAT DUE TO LECTURE THEATRE SEATING CAPACITY, IF YOU WISH TO ATTEND THIS EVENT YOU MUST REGISTER, OTHERWISE UNFORTUNATELY YOU WILL NOT BE ABLE TO GAIN ADMISSION. Seat allocation is on a first come, first served basis. If you wish to attend, all that is required is to email firstname.lastname@example.org with 'I will attend' in the subject box. Please only register if you can definitely make the meeting. If you have to cancel later do please let us know.
The LRMN Team very much look forward to welcoming you at 6.00pm on Monday 8th December 2014 for an event that will focus on the very latest in cell therapy commercialisation.
LRMN & Miltenyi
The LRMN is working together again with Miltenyi Biotec to hold another event in early Spring 2015.
Miltenyi provide products and services that advance biomedical research and cellular therapy. Regarding stem cell research, currently Mitenyi’s emphasis is on developing tools for the isolation, analysis, and culture of embryonic stem cells, induced pluripotent stem cells, tissue (e.g. neural, cardiac and hepatic) stem cells and cancer stem cells. The latest company developments focus on re-programming, directed differentiation and enrichment of the resulting differentiated cells.
More information on this event, including a finalised date and the programme will be given in due course, with invitations sent out to the LRMN mailing list as usual.